Versant Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-60
| Closed | -$88 | – | 2681 |
|
|
2025
Q1 | $88 | Sell |
60
-158
| -72% | -$232 | ﹤0.01% | 2491 |
|
|
2024
Q4 | $966 | Sell |
218
-2,586
| -92% | -$11.5K | ﹤0.01% | 2201 |
|
|
2024
Q3 | $11.6K | Buy |
2,804
+2,644
| +1,653% | +$10.9K | ﹤0.01% | 1008 |
|
|
2024
Q2 | $1.04K | Buy |
160
+100
| +167% | +$652 | ﹤0.01% | 1667 |
|
|
2024
Q1 | $523 | Hold |
60
| – | – | ﹤0.01% | 1682 |
|
|
2023
Q4 | $686 | Hold |
60
| – | – | ﹤0.01% | 1607 |
|
|
2023
Q3 | $578 | Sell |
60
-64
| -52% | -$617 | ﹤0.01% | 1664 |
|
|
2023
Q2 | $1.32K | Buy |
124
+64
| +107% | +$681 | ﹤0.01% | 1522 |
|
|
2023
Q1 | $631 | Hold |
60
| – | – | ﹤0.01% | 1552 |
|
|
2022
Q4 | $743 | Hold |
60
| – | – | ﹤0.01% | 1368 |
|
|
2022
Q3 | $1K | Sell |
60
-30
| -33% | -$500 | ﹤0.01% | 1260 |
|
|
2022
Q2 | $1K | Hold |
90
| – | – | ﹤0.01% | 1280 |
|
|
2022
Q1 | $1K | Buy |
90
+30
| +50% | +$333 | ﹤0.01% | 1296 |
|
|
2021
Q4 | $1K | Hold |
60
| – | – | ﹤0.01% | 1280 |
|
|
2021
Q3 | $1K | Hold |
60
| – | – | ﹤0.01% | 1286 |
|
|
2021
Q2 | $1K | Hold |
60
| – | – | ﹤0.01% | 1292 |
|
|
2021
Q1 | $1K | Hold |
60
| – | – | ﹤0.01% | 1375 |
|
|
2020
Q4 | $0 | Hold |
60
| – | – | ﹤0.01% | 1429 |
|
|
2020
Q3 | $0 | Hold |
60
| – | – | ﹤0.01% | 1399 |
|
|
2020
Q2 | $0 | Sell |
60
-20
| -25% | – | ﹤0.01% | 1424 |
|
|
2020
Q1 | $0 | Sell |
80
-13
| -14% | – | ﹤0.01% | 1486 |
|
|
2019
Q4 | $1K | Sell |
93
-42
| -31% | -$452 | ﹤0.01% | 1238 |
|
|
2019
Q3 | $1K | Buy |
135
+5
| +4% | +$37 | ﹤0.01% | 1256 |
|
|
2019
Q2 | $1K | Sell |
130
-44
| -25% | -$338 | ﹤0.01% | 1287 |
|
|
2019
Q1 | $1K | Buy |
+174
| New | +$1K | ﹤0.01% | 1446 |
|